Navigation Links
Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO

Madison, Wis. - In a merging of complementary companies, Cytochroma, Inc., a Canadian firm seeking to commercialize new Vitamin D products, has acquired Proventiv Therapeutics, LLC, of Madison, and the combined company is looking for an additional $25 million in venture capital from Canadian and American investors.

Proventiv was founded in Se......

Full article >>> are employee Keith H. Crawford, who will be vice president of strategic planning for Cytochroma.

Jay A. White, the new vice president of product development, is the former vice president of operations at Cytochroma.

Continuing in their present roles will be Martin Petkovich, chief scientific officer, and Jukka K. Karjalainen, vice president of clinical affairs.

Rae, Cyt......

Full article >>> F's goals," Block said in a statement.

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/29/06


Related biology technology :

1. GE Healthcare enters agreement with Canadian health authority
2. Canadian firm acquires Silicon Logic
3. Take off: Canadian biotech industry thrives
4. Merge eFilm corporate merger with Canadian firm moves ahead
5. Standard Imaging acquires Canadian PIPSpro radiation treatment technologies
6. Standard Imaging acquires Canadian PIPSpro radiation treatment technologies
7. EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products
8. BIO 2007: Wisconsin makes its presence felt
9. Tired of the spin? ExpertVoter website makes candidate selection easier
10. Whitewater makes plans for business incubator
11. Online service makes board connections
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology:
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
Breaking Biology News(10 mins):